KRAS and liver disorder: In multivariate analysis, KRAS mutation (HR, 1.495; 95% CI, 1.069–2.092; p = 0.019) and margin status (HR, 1.560; 95% CI, 1.017–3.033; p = 0.043) were significantly correlated with hepatic disease recurrence.